Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06309953
Status:
COMPLETED
Last Update Posted:
2024-06-21
First Post:
2024-03-07
Brief Title:
A Study to Evaluate Early Treatment Outcomes With Miebo in Subjects With Dry Eye Disease
Sponsor:
Bausch Lomb Incorporated
Organization:
Bausch Lomb Incorporated
Study Overview
Official Title:
An Open-Label Multicenter Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo in Subjects With Dry Eye Disease
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An Open-Label Multicenter Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo in Subjects With Dry Eye Disease
Detailed Description:
The primary objective of this study is to evaluate early outcomes with Miebo treatment in subjects with Dry Eye Disease DED
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None